欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/5270/001
药品名称	Methylphenidat-ratiopharm 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung
活性成分	methylphenidate hydrochloride 10.0 mg
剂型	Modified-release capsule, hard
上市许可持有人	ratiopharm GmbH Graf-Arco-Straße 3 89079 Ulm Germany
参考成员国 - 产品名称	Germany (DE) Methylphenidat-ratiopharm 10 mg Hartkapseln mit veränderter Wirkstofffreisetzung
互认成员国 - 产品名称	Denmark (DK) Methylphenidathydrochlorid "Develco Pharma" Iceland (IS) Methylphenidate Teva 10 mg hart hylki með breyttan losunarhraða Sweden (SE) Norway (NO) Methylphenidate Teva
许可日期	2018/08/13
最近更新日期	2024/04/03
药物ATC编码	N06BA04 methylphenidate
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final Product Information \| common-final-labip-5270-V005Date of last change:2019/11/22 Final Product Information \| common-final-labop-5270-V005Date of last change:2019/11/22 Final Product Information \| common-final-pl-5270-V005Date of last change:2019/11/22 Final Product Information \| common-final-spc-5270-V005Date of last change:2019/11/22 PAR \| 2200314-18,2200319-23-PAREN-DE 5270+5271_MethylphenidatDate of last change:2018/12/11 Final PL \| DE5270+5271_Methylphenidat_PLDate of last change:2018/11/07 Final SPC \| DE5270+5271_Methylphenidat_SmPCDate of last change:2018/11/07 Final Labelling \| DE5270+5271_Methylphenidat_labipDate of last change:2018/11/07 Final Labelling \| DE5270+5271_Methylphenidat_labopDate of last change:2018/11/07
市场状态	Positive